Associate Professor, Internal Medicine, Mayo Med Sch
Hematology
Dr. Ronald S. Go, MD
|
|
Give Review
Ronald practices Hematology. He studied medicine at Baylor College of Medicine. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Dr. Ronald S. Go has written publications. He has 74 publications published with PubMed. The lastest paper is: 'The natural history of asymptomatic meningiomas in Olmsted County, Minnesota.' Ronald S. Go, MD is registered with Medicare.
Publications
- Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic Lymphoma: A Wiscon...
- Outcomes of primary refractory multiple Myeloma and the impact of novel therapies.
- Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple Myeloma.
- Soluble suppression of tumorigenicity 2 (sST2), but not Galactin-3, adds to prognostication in patients with Systemic AL amyloidosis independent of NT-proBNP and Tropo...
- Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis.
- Anxiety and Health-Related Quality of Life Among Patients With Low-Tumor Burden Non-Hodgkin Lymphoma Randomly Assigned to Two Different Rituximab Dosing Regimens: Resu...
- Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma Cell dyscrasias.
- Stage redistribution and survival among Medicare beneficiaries before and after the approval of positron emission tomography scan for non-Hodgkin Lymphoma.
- Determining the Clinical Significance of Monoclonal Gammopathy of Undetermined Significance: A SEER-Medicare Population Analysis.
- Trends in survival of patients with primary plasma cell Leukemia: a population based analysis.
- Use of autologous hematopoietic Cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents.
- Long-term Disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy.
- Speed of Accrual Into Phase III Oncology Trials: A Comparison Across Geographic Locations.
- ECOG Phase II Trial of Graded-Dose Peginterferon α-2b in Patients with Metastatic Melanoma Overexpressing Basic Fibroblast Growth Factor (E2602).
- MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell Lymphoma patients treated with rituximab-CHOP immunochemotherapy.
- Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell Lymphoma treated with rituximab-CHOP: a report from the International DLBCL Ritu...
- Early-phase clinical trials in the community: results from the national Cancer institute community Cancer centers program early-phase working group baseline assessment.
- MYC/BCL2 protein co-expression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell Lymphoma and demonstrates high-risk gene expres...
- Patients with diffuse large B-cell Lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an Internat...
- CD30 expression defines a novel subset of diffuse large B-cell Lymphoma with favorable prognosis and distinct gene expression signature: a report from The Internationa...
- Utility of routine left ventricular ejection fraction measurement before anthracycline-based chemotherapy in patients with diffuse large B-cell Lymphoma.
- Proportions of bone marrow lymphocyte subsets at diagnosis may predict survival in patients with newly diagnosed diffuse large B-cell Lymphoma independently of the int...
- Floral variant of follicular Lymphoma.
- MicroRNA expression in diffuse large B-cell Lymphoma treated with chemoimmunotherapy.
- Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines.
- Monoclonal gammopathy of undetermined significance: to screen or not to screen for multiple Myeloma?
- Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell Lymphoma.
- Uncertainty and discordance in the staging and prognosis of diffuse large B-cell Lymphoma with isolated bilateral testicular involvement.
- Primary testicular diffuse large B-cell Lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart be...
- Emergence of chronic myelogenous Leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation.
- A monoclonal gammopathy in search of clinical significance: 57 years later.
- Smudge cells, serum albumin, and prognosis in B-cell chronic lymphocytic Leukemia.
- Publication outcomes of phase II oncology clinical trials.
- Improved quality of life for romiplostim-treated patients with Chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials.
- Extent and nature of advertising in leading hematology-oncology journals.
- Issues behind disclosure of conflicts of interest.
- Circulating endothelial cells in patients with chronic lymphocytic Leukemia.
- Efficacy of romiplostim in patients with Chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.
- Disclosure of financial conflicts of interest by authors publishing in the Journal of Clinical Oncology.
- Financial conflicts of interest among ASCO annual meeting abstract authors, speakers, and planners.
- Myeloproliferative Disorders with coexisting BCR-ABL translocation and JAK2(V617F) mutation.
- Re: Has demand for clinical trial participants outpaced supply?
- The association between platelet autoantibody specificity and response to intravenous immunoglobulin G in the treatment of patients with Immune thrombocytopenia.
- Pseudothrombocytopenia associated with multiple Myeloma.
- Clinical trial accrual among new Cancer patients at a community-based Cancer center.
- Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors.
- Macrocytosis associated with monoclonal gammopathy.
- Human cyclic thrombocytopenia and Anaplasma spp. infection.
- Idiopathic cyclic thrombocytopenia.
- Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a System...
- Catastrophic thromboembolism in a patient with Acute lymphoblastic leukemia and hypereosinophilia.
- Cranial vault Lymphoma.
- Angiogenesis in rat aortic rings stimulated by very low concentrations of serum and plasma.
- EDTA-dependent lymphocyte clumping.
- Aplastic anemia and pure red cell aplasia associated with large granular lymphocyte Leukemia.
- Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome.
- Subcutaneous panniculitis-like T-cell Lymphoma: complete remission with fludarabine.
- The rat aortic ring assay for in vitro study of angiogenesis.
- Correspondence re: K. Neben et al., high plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple Myeloma...
- Acquired pure red cell aplasia associated with lymphoproliferative Disease of granular T lymphocytes.
- Candidate genes showing no evidence for association or linkage with Alzheimer''s Disease using family-based methodologies.
- Lymphoproliferative disease of granular T lymphocytes presenting as aplastic Anemia.
- (13)C-urea breath test without a test meal is highly accurate for the detection of Helicobacter pylori infection in Chinese.
- 22-year-old woman with severe microcytic Anemia.
- Use of pleural fluid prostate specific antigen in the diagnosis of malignant effusion from metastatic prostate Cancer.
- Thrombocytopenia after iron dextran administration in a patient with severe iron deficiency Anemia.
- Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complic...
- Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin.
- The natural history of asymptomatic meningiomas in Olmsted County, Minnesota.
- Usefulness of ictal and interictal 99mTc ethyl cysteinate dimer single photon emission computed tomography in patients with refractory partial epilepsy.
- Improvement in renal function and its impact on survival in patients with newly diagnosed multiple Myeloma.
- A phase II study of sorafenib (BAY 43-9006) in recurrent diffuse large B cell Lymphoma: an eastern cooperative oncology group study (E1404).
- Occurrence and prognostic significance of cytogenetic evolution in patients with multiple Myeloma.
Schools
University Of Santo Tomas Faculty Of Medicine and Surgery
Baylor College Of Med
Mayo Clinic Rochester
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Mayo School of Graduate Medical Education -
Baylor College of Medicine -
University of Santo Tomas
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1891790515 | |
| NPPES Provider LastName | GO | |
| NPPES Provider FirstName | RONALD | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 223.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891790515 |
| Last Name Of The Provider | GO |
| First Name Of The Provider | RONALD |
| View All |
Similar Doctors
|
|
Dr. Christian O. Debranin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig E. Cole, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Wayne A. Bottner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sai R. Pingali, MD |
|
Dr. Michael O. Ojelabi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John P. Farnen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Roger W. Kwong, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sigurdur Bodvarsson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alcee J. Jumonville IV, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vinay S. Naik, MD |
|
Dr. David E. Marinier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert S. Witte, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kurt R. Oettel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amritha C. Karkera, MD |
|
|
Dr. David M. Loesch, MD
This Doctor is OpenDoctor Recommended.
|